Rubella revisited: Where are we on the road to disease elimination in Central Europe?Archived
Elimination of rubella and prevention of congenital rubella infection in Europe has been a high priority for the WHO European Regional Office over the past decade. In 2010 the WHO regional committee for Europe renewed its commitment to the elimination of rubella and prevention of CRS with a new target of 2015. For Central Europe to reach the target of rubella elimination and prevention of CRS by 2015, very high vaccine coverage levels need to be maintained and catch-up campaigns continued to address susceptible groups, in particular women of child-bearing age.
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
EU/EEA Member States prepare for next round in annual reporting for verification of measles and rubella elimination
The summary of the the first intercountry meeting, held in Copenhagen on 24-25 March 2015, hosted jointly by WHO/Europe and the European Centre for Disease Prevention and Control (ECDC) to address issues encountered by the national verfication committeees in European Union (EU)/European Economic Area (EEA) Member States.
2015 Measles and Rubella Monitoring Report now available
3 969 cases of measles were reported by 30 EU/EEA countries from 1 January to 31 December 2015, according to ECDC’s latest measles and rubella monitoring report. One measles-related death was reported in a 19 month old child, and six cases were complicated by acute measles encephalitis.
ECDC and WHO Europe release “MESSAGE” - a tool to assess progress towards measles and rubella eliminationArchived
ECDC and WHO Europe jointly release “MESSAGE - MEaSles and rubella Self Assessment GEnerating tool” for public health experts, to facilitate assessment of the progress made towards measles and rubella elimination.